Ignite Creation Date:
2024-05-05 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 9:47 AM
Study NCT ID:
NCT00646087
Status:
WITHDRAWN
Last Update Posted:
2011-06-06
First Post:
2008-03-25
Brief Title:
Ketamine Frequency Treatment for Major Depressive Disorder
Sponsor:
Essentia Health
Organization:
Essentia Health
Study Overview
Official Title:
Ketamine Frequency Treatment for Major Depressive Disorder
Status:
WITHDRAWN
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Pilot study determined that this study would not be feasible
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Depression is a wide spread illness Depression contributes most significantly to national health care costs While the number and types of treatments used for depression have expanded over the years even with an increased range of options the response rate defined as the number of subjects who have a 50 reduction in depressive symptoms is estimated to be around 65
This randomized clinical trial will examine the frequency of treatment with ketamine in patients with treatment-resistant depression TRD without psychosis It will compare two modes of the ketamine treatment every other day ketamine versus two active and four placebo treatments over the period of 12 days
This randomized clinical trial will examine the frequency of treatment with ketamine in patients with treatment-resistant depression TRD without psychosis It will compare two modes of the ketamine treatment every other day ketamine versus two active and four placebo treatments over the period of 12 days
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None